We are live on !
Find out more
McAdam LLC Portfolio holdings
AUM
$2.59B
Turnover
26.26%
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+21.24%
3 Year Est. Return
+57.44%
5 Year Est. Return
+51.44%
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
+$156M
(+7.7%)
Cap. Flow
+$124M
Cap. Flow % of AUM
Cap. Flow %
5.67%
Top 10 Holdings %
Top 10 Hldgs %
59.25%
Holding
447
New
52
Increased
245
Reduced
121
Closed
16
Avg Time Held
Equity + Options
2.9
years
Top 10 Avg Time Held
Equity + Options
6.7
years
Top 20 Avg Time Held
Equity + Options
4.5
years
Avg Time Held Equity only
2.9
years
Top 10 Avg Time Held Equity only
6.7
years
Top 20 Avg Time Held Equity only
4.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$17.4M |
| 2 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$11.5M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$8.08M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$7.9M |
| 5 |
Schwab International Small-Cap Equity ETF
SCHC
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$613K |
| 2 |
iShares Russell Top 200 Growth ETF
IWY
|
+$439K |
| 3 |
Zscaler
ZS
|
+$353K |
| 4 |
Kopin
KOPN
|
+$333K |
| 5 |
Kimberly-Clark
KMB
|
+$316K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.7% |
| 2 | Technology | 3.65% |
| 3 | Financials | 1.04% |
| 4 | Communication Services | 1.02% |
| 5 | Healthcare | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Amphenol
APH
$196B
| $308K | 0.01% |
4,560
-100
| -2% | -$6.69K |
2025 Q2
2 quarters
|
|
327
FedEx
FDX
$69.5B
| $307K | 0.01% |
1,063
+87
| +9% | +$22.8K |
2025 Q3
1 quarter
|
|
328
Intercontinental Exchange
ICE
$90.7B
| $298K | 0.01% |
1,838
+42
| +2% | +$6.58K |
2024 Q2
6 quarters
|
|
329
iShares Residential and Multisector Real Estate ETF
REZ
$799M
| $291K | 0.01% |
3,525
+660
| +23% | +$55.3K |
2023 Q1
11 quarters
|
|
330
State Street SPDR Russell 1000 Yield Focus ETF
ONEY
$649M
| $290K | 0.01% |
2,552
-68
| -3% | -$7.69K |
2024 Q1
7 quarters
|
|
331
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.67B
| $289K | 0.01% |
3,051
+120
| +4% | +$11.4K |
2025 Q3
1 quarter
|
|
332
AstraZeneca
AZN
$257B
| $289K | 0.01% |
1,572
-12
| -0.8% | -$2.1K |
2025 Q3
1 quarter
|
|
333
CVS Health
CVS
$118B
| $286K | 0.01% |
3,603
+771
| +27% | +$60.8K |
2025 Q3
1 quarter
|
|
334
State Street SPDR Portfolio S&P 500 ETF
SPYM
$176B
| $280K | 0.01% |
+3,493
| New | +$278K |
2025 Q4
0 quarters
|
|
335
Vanguard Real Estate ETF
VNQ
$36.8B
| $280K | 0.01% |
3,159
+2
| +0.1% | +$180 |
2023 Q1
11 quarters
|
|
336
Strategy Inc
MSTR
$57.9B
| $279K | 0.01% |
1,837
+112
| +6% | +$25.8K |
2024 Q4
4 quarters
|
|
337
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $279K | 0.01% |
3,443
-142
| -4% | -$11.2K |
2024 Q1
7 quarters
|
|
338
Idexx Laboratories
IDXX
$44.1B
| $278K | 0.01% |
412
+36
| +10% | +$24.5K |
2025 Q3
1 quarter
|
|
339
Boston Scientific
BSX
$64.3B
| $275K | 0.01% |
2,889
-78
| -3% | -$7.65K |
2024 Q3
5 quarters
|
|
340
VanEck Short High Yield Muni ETF
SHYD
$486M
| $275K | 0.01% |
11,994
-174
| -1% | -$3.97K |
2020 Q1
23 quarters
|
|
341
Altria Group
MO
$125B
| $273K | 0.01% |
4,740
+574
| +14% | +$34.7K |
2024 Q4
4 quarters
|
|
342
iShares Emerging Markets Equity Factor ETF
EMGF
$1.83B
| $271K | 0.01% |
4,686
-22
| -0.5% | -$1.27K |
2025 Q2
2 quarters
|
|
343
Stryker
SYK
$113B
| $270K | 0.01% |
769
+8
| +1% | +$2.92K |
2023 Q4
8 quarters
|
|
344
Nuveen ESG Mid-Cap Value ETF
NUMV
$446M
| $269K | 0.01% |
6,891
-23
| -0.3% | -$893 |
2025 Q1
3 quarters
|
|
345
Vanguard Health Care ETF
VHT
$19.8B
| $269K | 0.01% |
934
-3
| -0.3% | -$838 |
2023 Q1
11 quarters
|
|
346
Thermo Fisher Scientific
TMO
$255B
| $267K | 0.01% |
+461
| New | +$261K |
2025 Q4
0 quarters
|
|
347
Phillips 66
PSX
$117B
| $267K | 0.01% |
2,068
+208
| +11% | +$28K |
2025 Q1
3 quarters
|
|
348
Invesco NASDAQ 100 ETF
QQQM
$106B
| $264K | 0.01% |
1,043
+26
| +3% | +$6.57K |
2025 Q2
2 quarters
|
|
349
Dow Inc
DOW
$21.6B
| $262K | 0.01% |
11,205
+183
| +2% | +$4.21K |
2020 Q1
23 quarters
|
|
350
Vertex Pharmaceuticals
VRTX
$127B
| $258K | 0.01% |
569
-171
| -23% | -$73.7K |
2019 Q4
24 quarters
|
|
Similar funds
McAdam LLC's Q4 2025 Portfolio in Review
As of Q4 2025, McAdam LLC held 447 positions worth $2.19B, up 7.7% from $2.03B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
McAdam LLC deployed $124M of net new capital in Q4 2025, opening 52 new positions and adding to 245 existing holdings. Its largest new stake was Franklin Massachusetts Municipal Income ETF: 224,447 shares worth $2.02M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Schwab Emerging Markets Equity ETF, an estimated $613K trimmed.
- McAdam LLC's largest Q4 2025 buy was Franklin Massachusetts Municipal Income ETF: 224,447 shares worth $2.02M.
- McAdam LLC added most to Schwab International Equity ETF in Q4 2025, an estimated $17.4M increase.
- McAdam LLC's biggest Q4 2025 reduction was Schwab Emerging Markets Equity ETF, cutting an estimated $613K.
- McAdam LLC fully exited Zscaler in Q4 2025, selling an estimated $353K.
- McAdam LLC's ten largest holdings make up 59% of its $2.19B portfolio in Q4 2025.
- McAdam LLC opened 52 new positions and closed 16 in Q4 2025.
- McAdam LLC's portfolio value rose 7.7% quarter-over-quarter to $2.19B.
Based on McAdam LLC's 13F filing for Q4 2025, filed 13 Feb 2026.